Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | FPR2 | P25090 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 2/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | LDHB | P07195 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1594751 | 0.76 | PPARG (0.53) | CNR2MTORPPARGPPARAMDM2 | |
| SCHEMBL1594754 | 0.76 | PPARG (0.53) | CNR2MTORPPARGPPARAMDM2 | |
| SCHEMBL6880963 | 0.74 | PDPK1 (0.60) | PDPK1CNR2PPARGPPARAACP3 | |
| SCHEMBL28209100 | 0.72 | PPARG (0.58) | PDPK1CNR2PPARGPPARAFPR2 | |
| SCHEMBL4297567 | 0.71 | MTOR (0.49) | CNR2MTORPPARGPPARAMDM2 | |
| SCHEMBL4297563 | 0.71 | MTOR (0.49) | CNR2MTORPPARGPPARAMDM2 | |
| SCHEMBL8818382 | 0.71 | LMNA (0.42) | MEN1KMT2A | |
| SCHEMBL20791192 | 0.69 | PDE2A (0.45) | MTORPPARGPPARAMDM2MEN1 | |
| SCHEMBL8067663 | 0.69 | HSD11B1 (0.47) | CNR2MTORTMEM97SIGMAR1HSD11B1 | |
| SCHEMBL27683652 | 0.69 | ACP3 (0.59) | PDPK1CNR2PPARGPPARAACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847177-B1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | BOEHRINGER INGELHEIM INT (DE) | 2017-10-11 | — | — | EP | disclosed |
| US-9376409-B2 | Methods for making oxetan-3-ylmethanamines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2016-06-28 | — | — | US | disclosed |
| US-20150119589-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-04-30 | — | — | US | disclosed |
| EP-2847177-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | Boehringer Ingelheim International GmbH (DE) | 2015-03-18 | — | — | EP | disclosed |
| WO-2013169531-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119589-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | ODC1, PNMT, OXTR | PDPK1 2715/4885CNR2 290/4885MTOR 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.